Pepsinogen I
Pepsinogens are inactive precursors of pepsin, the primary gastric enzyme responsible for protein digestion. Two major isoforms exist: pepsinogen I (PG I) and pepsinogen II (PG II). PG I is secreted mainly by the chief and mucous neck cells of the gastric fundic glands, while PG II originates from the pyloric glands in the gastric antrum and proximal duodenum.
Approximately two-thirds of PG I is metabolized by the kidneys, whereas PG II is almost entirely cleared renally. Measurement of serum pepsinogens serves as a non-invasive biomarker of gastric mucosal health. PG I levels correlate with gastric acid secretory capacity and mucosal integrity.
In atrophic gastritis, destruction of acid-secreting parietal cells and chief cells results in reduced secretion of PG I. This may occur due to autoimmune-mediated parietal cell destruction (Type A atrophic gastritis) or H. pylori associated chronic gastritis (Type B). A low PG I level or a decreased PG I/PG II ratio is a strong serological marker of gastric atrophy, which is a precursor lesion for gastric cancer.
Conversely, PG I levels are elevated in hypersecretory conditions such as Zollinger–Ellison syndrome, peptic ulcer disease, chronic gastritis, and H. pylori infection. Evaluation of PG I, often in combination with PG II and serum gastrin, can provide important insights into gastric functional status, the presence of atrophic changes, and risk for malignant transformation.
- As an aid in the diagnosis of atrophic gastritis
- Non-invasive biomarker for monitoring H. pylori infection and treatment response
- Useful as a gastric cancer screening tool in high-risk populations (as part of the “serological gastric biopsy”)
- Monitoring gastric mucosal changes in patients with pernicious anemia or other causes of gastric atrophy
Increased in:
- Zollinger-Ellison syndrome
- Gastric ulcers
- Gastroesophageal reflux disease
- Chronic gastritis
- Helicobacter pylori infection
Decreased in:
- Atrophic gastritis
- Pernicious anemia
- Gastric cancer
- Severe chronic gastritis
- Gastric mucosal atrophy
- Gastrectomy
24 – 214 ng/mL
Serum, Red top tube.
Stability
- Ambient: 3 days
- Refrigerated: 7 days
- Frozen: 30 days
- Pharmacol Res. 2000 Mar;41(3):265-81. [PMID: 10675278]
- J Int Med Res. 2020 Mar;48(3):300060520914826. [PMID: 32228342]
- World J Gastrointest Oncol. 2023 Jul 15;15(7):1174-1181. [PMID: 37546552]
- Trop Gastroenterol. 2011 Oct-Dec;32(4):292-8. [PMID: 22696910]
- Clin Lab. 2002;48(9-10):505-15. [PMID: 12389711]